Vical News
Most Popular Vical Story
Glaxo fields big H1N1 vax orders as Vical starts testing
GlaxoSmithKline has already received orders for 128 million doses of a new swine flu vaccine that has yet to be developed. And the pharma giant says that it expects many, many more requests before... Read more...
Latest Headlines
- January 12, 2010
- October 1, 2009
- September 10, 2009
- July 1, 2009
- November 5, 2008
- July 17, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
